Similarly, miR-29a has been suggested to contribute to the pathogenesis of tubulointerstitial fibrosis by modulating the CB1R pathway, thereby accelerating the progression of diabetic nephropathy [46]. Here, CNR1 is linked to diabetic kidney disease.